Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02615912 · ClinicalTrials.gov registry record · NA
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
A NA study, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02615912 is a NA study that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 24 participants.
The verdict
NCT02615912, a NA study, has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the changes in skin microflora, skin barrier function, and skin biochemical constituents in response to direct contact with model surfactants used in personal care articles. The results from this study will provide insights into the complex interaction between the skin microbiome and the epidermis after exposure to surfactants.
Interventions
- OTHER PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5%
- OTHER Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5%
- OTHER Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5%
- OTHER Silwet* DA-63 (Momentive) 1.5%
- OTHER Sodium lauryl sulfate (Sigma Aldrich) 1.0%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-11 |
| Est. Completion | 2016-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02615912
The ClinicalTrials.gov registry entry for NCT02615912 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kimberly-Clark Corporation, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5% is the first listed.
NCT02615912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02615912 about?
NCT02615912 is a clinical study titled "A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants". The purpose of this study is to understand the changes in skin microflora, skin barrier function, and skin biochemical constituents in response to direct contact with model surfactants used in personal care articles. The results from this study will provide insights into the complex interaction betw...
What is the current status of trial NCT02615912?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2015-11. Estimated completion is 2016-02.
What interventions are being tested in trial NCT02615912?
The interventions under investigation include: PEG-40 Hydrogenated Castor Oil (Tagat CH40, Evonik) 1.5% (OTHER), Lauryl glucoside (Plantacare® 1200UP, BASF) 1.5% (OTHER), Sorbitan palmitate (SPANTM 40 (powder), Croda) 1.5% (OTHER), Silwet* DA-63 (Momentive) 1.5% (OTHER), Sodium lauryl sulfate (Sigma Aldrich) 1.0% (OTHER).
Who is sponsoring clinical trial NCT02615912?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.